.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Eszopiclone - Generic Drug Details

« Back to Dashboard
Eszopiclone is the generic ingredient in two branded drugs marketed by Sun Pharma Global, Orchid Hlthcare, Dr Reddys Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Roxane, Wockhardt Ltd, Glenmark Generics, Teva, and Sunovion Pharms Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for eszopiclone. Thirty-three suppliers are listed for this compound.

Summary for Generic Name: eszopiclone

Tradenames:2
Patents:0
Applicants:11
NDAs:11
Drug Master File Entries: see list20
Suppliers / Packaging: see list33
Therapeutic Class:Sedatives/Hypnotics
Formulation / Manufacturing:see details
Drug Prices:see low prices

Clinical Trials for: eszopiclone

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL091124-003Sep 13, 2011RXNo
Wockhardt Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL091165-002Jul 14, 2011DISCNNo
Mylan Pharms Inc
ESZOPICLONE
eszopiclone
TABLET;ORAL091151-003Mar 26, 2013RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: eszopiclone

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-001Dec 15, 20046,864,257*PED<disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-003Dec 15, 20046,444,673*PED<disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-002Dec 15, 20046,864,257*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc